Pfizer announced that an early analysis of its COVID-19 vaccine trial suggested it was 90% effective in preventing the disease. It may begin manufacturing millions of vaccine doses this year. How much credit, if any, do you believe President Donald Trump should receive for the vaccine's possible readiness? | Daily Question

Pfizer announced that an early analysis of its COVID‑19 vaccine trial suggested it was 90% effective in preventing the disease. It may begin manufacturing millions of vaccine doses this year. How much credit, if any, do you believe President Donald Trump should receive for the vaccine's possible readiness? Published on November 10, 2020 → Survey conducted on November 10, 2020 on 5675 U.S. adults

All adults

Region

Gender

Politics

Age

A lot

25%

Some

14%

Not very much

15%

Not at all

37%

Don't know

10%

A lot

25%

Some

14%

Not very much

15%

Not at all

37%

Don't know

10%